Search research articles
Contact Us
Filters
Showing results (51-60 of 55) with videos related to
Page
of 6
Sort By:
You have reached the last page of results.
This site can display upto 55 results.
British Journal of Haematology
|
July 25, 2019
Genotype/phenotype correlations of childhood-onset congenital sideroblastic anaemia in a European cohort
Cyrielle Fouquet, Marie-Amelyne Le Rouzic, Thierry Leblanc, et al.
Blood
|
January 25, 2002
Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial
Philippe Moreau, Thierry Facon, Michel Attal, et al.
Blood
|
May 16, 2023
Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma
Blandine Pouleau, Carole Estoppey, Perrine Suere, et al.
Molecular Cancer Therapeutics
|
May 11, 2018
Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and Leukemia
Vanessa Buatois, Zoë Johnson, Susana Salgado-Pires, et al.
Nature Cancer
|
September 11, 2024
ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells
Laura Carretero-Iglesia, Olivia J Hall, Jérémy Berret, et al.
Page
of 6
Search research articles
Search
Showing results (51-60 of 55) with videos related to
Sort By:
Page
of 6
You have reached the last page of results.
This site can display upto 55 results.
British Journal of Haematology
|
July 25, 2019
Genotype/phenotype correlations of childhood-onset congenital sideroblastic anaemia in a European cohort
Cyrielle Fouquet, Marie-Amelyne Le Rouzic, Thierry Leblanc, et al.
Blood
|
January 25, 2002
Comparison of 200 mg/m(2) melphalan and 8 Gy total body irradiation plus 140 mg/m(2) melphalan as conditioning regimens for peripheral blood stem cell transplantation in patients with newly diagnosed multiple myeloma: final analysis of the Intergroupe Francophone du Myélome 9502 randomized trial
Philippe Moreau, Thierry Facon, Michel Attal, et al.
Blood
|
May 16, 2023
Preclinical characterization of ISB 1342, a CD38 × CD3 T-cell engager for relapsed/refractory multiple myeloma
Blandine Pouleau, Carole Estoppey, Perrine Suere, et al.
Molecular Cancer Therapeutics
|
May 11, 2018
Preclinical Development of a Bispecific Antibody that Safely and Effectively Targets CD19 and CD47 for the Treatment of B-Cell Lymphoma and Leukemia
Vanessa Buatois, Zoë Johnson, Susana Salgado-Pires, et al.
Nature Cancer
|
September 11, 2024
ISB 2001 trispecific T cell engager shows strong tumor cytotoxicity and overcomes immune escape mechanisms of multiple myeloma cells
Laura Carretero-Iglesia, Olivia J Hall, Jérémy Berret, et al.
Page
of 6